November 23, 2012 – Atorvastatin pills, the generic version of the drug Lipitor, will be recalled due to possible glass contamination, its Indian manufacturer announced. Ranbaxy Laboratories Ltd., India’s largest pharmaceutical company, said Friday small particles of glass, less than 1 millimeter (.039 inch) in size, may be in select batches of 10 milligram, 20 [...]

Reckitt Benckiser announced in September 2012 plans to discontinue Suboxone (buprenorphine/naloxone combination) in sublingual tablet formulation during the next 6 months. Information available on the Suboxone website recommends that patients replace the tablet formulation with the sublingual film, designed to dissolve under the tongue. The manufacturer cites several reasons for the change, including improved child-safety [...]

Background Lidoderm® (lidocaine Patch 5%) is a pain medication that has become a popular option for Injured Workers.  It is currently the best-selling product for its developer, Endo Pharmaceuticals. While a popular option, Lidoderm® is also an expensive option at this time.  This will likely change in the near future.  A recent lawsuit was settled, [...]

September 12, 2012 – Qualitest, a subsidiary of Endo Health Solutions,issued a voluntary, nationwide retail level recall for one lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg. Bottles from the affected lot may contain tablets that have a higher dosage of acetaminophen, and as a result, it is possible that consumers could [...]

The U.S. Food and Drug Administration is warning consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries’ Adderall 30 milligram tablets that is being purchased on the Internet. Adderall, which is approved to treat attention deficit hyperactivity disorders (ADHD) and narcolepsy, is a prescription drug classified as a controlled substance – [...]